Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the recipient of a large increase in short interest in November. As of November 15th, there was short interest totalling 56,900 shares, an increase of 341.1% from the October 31st total of 12,900 shares. Based on an average daily volume of 154,600 shares, the days-to-cover ratio is presently 0.4 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research report on Thursday, September 19th. They issued a “buy” rating on the stock.
Check Out Our Latest Research Report on Merck KGaA
Merck KGaA Stock Up 0.6 %
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Following Congress Stock Trades
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Energy and Oil Stocks Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How is Compound Interest Calculated?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.